Pricing Log in Create free account

Foghorn Therapeutics Inc. (FHTX) vs Minerva Neurosciences, Inc (NERV)

Foghorn Therapeutics Inc. and Minerva Neurosciences, Inc are both Biotechnology companies. Foghorn Therapeutics Inc. and Minerva Neurosciences, Inc are of similar size ($115.6M and $112.2M). Minerva Neurosciences, Inc has the higher net margin (0.00% vs −175.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Minerva Neurosciences, Inc leads on 6 and Foghorn Therapeutics Inc. on 5.

Valuation

Metric FHTX NERV Biotechnology median
P/E n/m n/m 8.50
P/S 3.56 n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.24 n/m 0.64
EV/Sales (0.46) n/m 9.21
Earnings yield (52.97%) (1,207.23%) (33.15%)
Free cash flow yield (64.53%) (24.00%) (25.50%)

Profitability

Metric FHTX NERV Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (198.04%) 0.00% 0.00%
Net margin (175.78%) 0.00% 0.00%
Free cash flow margin (229.49%) 0.00% 0.00%
Return on equity 81.90% 322.05% (56.36%)
Return on assets (30.06%) (629.71%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric FHTX NERV Biotechnology median
Revenue growth (TTM) 51.98% — 6.02%
EPS growth (last fiscal year) 25.32% (18,347.37%) 30.26%
Revenue growth, 5-year CAGR 135.14% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FHTX NERV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.36 20.14 4.72
Net debt to EBITDA 1.88 5.46 0.96

Dividend

Metric FHTX NERV Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FHTX NERV Biotechnology median
Market cap 112.24m 115.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack